Partners

GEMoaB Monoclonals GmbH is working with several companies and partners interested in the joint development of novel therapeutics based on our platform technology. We are open for new strategic collaborations and also ready to generate a bi-specific antibody based on your target binding moiety of choice. Please contact us for further details.

Fraunhofer Institute for Toxicology and Experimental Medicine
Cellex Gesellschaft für Zellgewinnung GmbH
CMT Cellex Medical Transports
CMS Cellex Medical Services
CPT Cellex Patient Treatment GmbH
Celgene Corporation

 

Supported by SAB Sächsische Aufbaubank-Förderbank
European Union/ European Social Fund

 

Dias
gemoab-40.jpg
gemoab-36.jpg
gemoab-54.jpg